CLINICAL ANALYSIS OF THE USE OF DRUG TONSILGON N IN CHILDREN FOR THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS, ACCOMPANIED BY A SORE THROAT

The improvement of approaches to prevention and treatment of acute respiratory infections (ARI) in children is important for the general pediatric practice. Polypharmacy in this pathology, unfortunately, remains a daily reality. A wide range of non-specific drugs for the treatment of diseases of the respiratory tract poses a difficult task to practitioner for choosing the most effective agents with minimum number of side effects and unwanted effects. The aim of the study was to compare the efficacy of monotherapy with Tonsilgon N and combination therapy with symptomatic treatment traditionally carried out for «sore throat» syndrome on the background of acute respiratory viral infections in children. The study included 71 children aged 2-12 years with ARI and «sore throat» symptom, receiving treatment in outpatient settings. Evaluation of clinical symptoms of ARI was performed by the attending physician using 4-point scale for the assessment of the severity of the symptom (0 - no symptom, 1 - mild symptom, 2 - moderate symptom, 3 - severe symptom, 4 - the most pronounced manifestations); data from the diary of symptoms, which was completed by parents, were considered. It was found that the complex therapy of children with the syndrome of «sore throat» in the background of ARI with the inclusion of the drug Tonsilgon N, taking into account the basic clinical assessment criteria, led to the earlier improvement in children, and reduced duration of treatment.

acute respiratory infections in children, sore throat, Tonsilgon N